Aggressive Glucose Control in Patients With Diabetes and Kidney Disease Not Associated With Improved Survival
A study suggests that in the absence of randomized controlled trials, aggressive management of HbA1c levels in patients with diabetes and end-stage kidney failure is not warranted.
Medscape Medical News
First-line Latanoprost Therapy in Ocular Hypertension or Open-angle Glaucoma Patients: a 3-month Efficacy Analysis Stratified by Initial Intraocular Pressure
How effective is latanoprost in the treatment of both glaucoma and ocular hypertension?
BMC Ophthalmology
How to Clean Up in Family Medicine
Would you and your staff be willing to clean toilets to keep your practice viable? Here's an example of creative cost-cutting.
Family Practice Management
Sanofi-Aventis Sues FDA Over Generic Lovenox Approval
The Lovenox manufacturer wants the FDA to reverse the approval decision it made last week, on grounds that the generic product is not clinically equivalent to its own product.
Heartwire
FDA Approves Glycopyrrolate Oral Solution for Chronic Severe Drooling
The FDA has approved glycopyrrolate oral solution for the treatment of patients aged 3 to 16 years with chronic severe drooling associated with neurologic conditions, such as cerebral palsy.
Medscape Medical News